Literature DB >> 30912839

Thyroglobulin for Monitoring for Thyroid Cancer Recurrence.

Alan N Peiris1,2, Dillon Medlock2, Meredith Gavin2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30912839     DOI: 10.1001/jama.2019.0803

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  5 in total

1.  Leveraging Genetic Reports and Electronic Health Records for the Prediction of Primary Cancers: Algorithm Development and Validation Study.

Authors:  Nansu Zong; Victoria Ngo; Daniel J Stone; Andrew Wen; Yiqing Zhao; Yue Yu; Sijia Liu; Ming Huang; Chen Wang; Guoqian Jiang
Journal:  JMIR Med Inform       Date:  2021-05-25

2.  miR-451a inhibits cancer growth, epithelial-mesenchymal transition and induces apoptosis in papillary thyroid cancer by targeting PSMB8.

Authors:  Xinlong Fan; Yuejiao Zhao
Journal:  J Cell Mol Med       Date:  2019-09-27       Impact factor: 5.310

3.  Papillary Thyroid Carcinoma: An Autobiographical Case Report.

Authors:  Joshua C Hunsaker; Greg Hoffman
Journal:  Cureus       Date:  2022-02-24

4.  Nomogram model based on preoperative serum thyroglobulin and clinical characteristics of papillary thyroid carcinoma to predict cervical lymph node metastasis.

Authors:  Qungang Chang; Jieming Zhang; Yaqian Wang; Hongqiang Li; Xin Du; Daohong Zuo; Detao Yin
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-15       Impact factor: 6.055

5.  Indoleamine 2,3-Dioxygenase Immune Status as a Potential Biomarker of Radioiodine Efficacy for Advanced Distant Metastatic Differentiated Thyroid Cancer.

Authors:  Liang Shi; Rui Duan; Qiong Jia; Wenyu Wu; Jianming Zhou; Shaohua Li; Hao Zhang; Xue Xue
Journal:  Front Oncol       Date:  2022-07-18       Impact factor: 5.738

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.